These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24245437)

  • 1. Does bupropion use lead to better outcome in smoking cessation patients motivated to stop smoking compared to the nicotine patch alone?
    Bristow ST; Wright A; Weaver N; Palmer PR
    J Okla State Med Assoc; 2013 Aug; 106(8):321-2. PubMed ID: 24245437
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
    Higashi H; Barendregt JJ
    Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion sustained release and smoking cessation.
    Goldstein MG
    J Clin Psychiatry; 1998; 59 Suppl 4():66-72. PubMed ID: 9554323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of bupropion hydrochloride for smoking cessation therapy.
    Nichols MR
    Clin Excell Nurse Pract; 1999 Nov; 3(6):317-22. PubMed ID: 10865568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressive drug against nicotine. A method for smoking cessation].
    Haustein KO
    MMW Fortschr Med; 2000 Dec; 142(51-52):44-6. PubMed ID: 11194275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation intervention: an evidence-based approach.
    Laniado-Laborín R
    Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Smoking cessation in medical practice--new possibilities?].
    Schuurmans MM; Zellweger JP
    Rev Med Suisse; 2012 Jan; 8(325):235-6. PubMed ID: 22338532
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes from a patient-centered residential treatment plan for tobacco dependence.
    Hodgkin JE; Sachs DP; Swan GE; Jack LM; Titus BL; Waldron SJ; Sachs BL; Brigham J
    Mayo Clin Proc; 2013 Sep; 88(9):970-6. PubMed ID: 24001489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation.
    Gifford EV; Kohlenberg BS; Hayes SC; Pierson HM; Piasecki MP; Antonuccio DO; Palm KM
    Behav Ther; 2011 Dec; 42(4):700-15. PubMed ID: 22035998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion or patch for smoking cessation?
    Kane KY; Ellis MR
    J Fam Pract; 1999 Jun; 48(6):419. PubMed ID: 10386482
    [No Abstract]   [Full Text] [Related]  

  • 18. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
    Wynn WP; Stroman RT; Almgren MM; Clark KJ
    J Pharm Pract; 2012 Dec; 25(6):591-9. PubMed ID: 23222855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.